Latest Viral hepatitis Stories
BOSTON, MA, Nov. 10, 2012 /CNW/ - Merck announced interim results from a Phase II, multi-center, randomized, dose-ranging study (n=332) assessing the safety and antiviral activity of MK-5172, an investigational, once-daily, oral NS3/4A protease inhibitor for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection in combination therapy in treatment-naïve patients. These data will be presented this week at The American Association for the Study of Liver Diseases...
BOSTON, Nov. 10, 2012 /PRNewswire/ -- The American Association for the Study of Liver Diseases (www.aasld.org) today announced a new initiative to provide ongoing education and training to healthcare professionals treating liver diseases. AASLD Curriculum & Training (ACT) will deliver reliable information and instruction for the treatment of patients with a variety of liver diseases including viral hepatitis. The first program to be released, ACT on HCV, A Practical...
BOSTON, MA, Nov. 10, 2012 /CNW/ - Merck announced interim results from a Phase II, multi-center, randomized, dose-ranging study (n=332) assessing the safety and antiviral activity of MK-5172, an investigational, once-daily, oral NS3/4A protease inhibitor for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection in combination therapy in treatment-naïve patients. These data will be presented this week at The American Association for the Study of Liver Diseases...
NEW YORK, Nov. 7, 2012 /PRNewswire/ -- The Bristol-Myers Squibb Foundation (the Foundation) and its partners today launched a Centers of Excellence Conference for Community Based Viral Hepatitis Interventions to share best practices from the flagship hepatitis program Delivering Hope, which this year celebrates its 10(th) anniversary. The Centers of Excellence conference is based on 10 years of developing strategies to raise awareness of hepatitis B and C and manage the virus in...
BRUSSELS, November 6, 2012 /PRNewswire/ -- International index on hepatitis care performance reveals deficits in screening and stark inequality in care performance levels between EU Member States - EU coordination for national activities necessary - Publication on 6 November in Brussels Population screening especially in risk groups is not conducted systematically in most EU Member States, making it the weakest spot of hepatitis care policies in comparison to prevention...
BOSTON, Nov. 2, 2012 /PRNewswire/ -- Late-breaking Oral SessionMonday, November 12, 2012 - 3:00-4:30 pmAuditorium, Hynes Convention Center The six abstracts that will be presented at our late-breaking oral session relate to new therapies for patients with chronic liver diseases. Four of the six studies (see numbers 1 - 4 below) report on the results of oral therapy for the treatment of hepatitis C, a disease that affects more than 3 million Americans and that is currently...
CDC Calls for HEP-C Testing for People Born between 1945-1965 Lab test can identify virus and help prevent an estimated 120,000 deaths WASHINGTON, Nov. 1, 2012 /PRNewswire-USNewswire/ -- In addition to Elvis, the Beatles, and advancing waistlines, baby boomers now have one more thing in common -- they need to get a test for the Hepatitis C virus. In August, the Centers for Disease Control and Prevention (CDC) issued a recommendation that people born between 1945 and 1965 receive a...
On August 24th, 2012 BusinessWeek reported that Elli Lilly’s experimental new drug for the treatment of Alzheimer’s disease delayed the worsening of mental loss, in a sub-analysis of patients in the earliest stage of the disease, while failing to meet the primary goals of two large trials. The only other therapy in final-stage testing is Baxter International Inc.’s Gammagard, an intravenous solution that is made from human plasma. At the end of February 1994, Baxter announced it was...
In August 2012, Baxter announced that it will discontinue manufacturing Gammagard S/D [Immune Globulin Intravenous (Human)] as of December 2012. Gammagard is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body maintain immunity and fight disease. At the end of February 1994, Baxter announced it was removing it from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now,...
Connie K. Ho for redOrbit.com – Your Universe Online The Centers for Disease Control and Prevention (CDC) recently advised that around two million baby boomers should get examined for the hepatitis C virus. Leaving the virus untreated can lead to cirrhosis and liver cancer. The recommendation was included in the latest Morbidity and Mortality Weekly Report. To begin, CDC officials stated that many people weren’t aware that they were infected with the virus and it can take decades...
Latest Viral hepatitis Reference Libraries
Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...
Hepatitis A, caused by hepatitis A virus, is an acute infectious disease of the liver that is transmitted person to person by ingestion of contaminated food or water or through direct contact with an infectious person. Millions of people are believed to become infected with HAV every year. The incubation period is two to six weeks and on average is 28 days. In less developed countries the HAV is usually contracted in early childhood. Clean water helps to decrease contraction of HAV. In 90%...
Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...
Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...
Hepadnaviruses can cause liver infections in humans and animals. The two recognized genera are Genus Orthohepadnavirus and Genus Avihepadnavirus. It has a small genome of partially double-stranded, partially single stranded circular DNA. It is a group 7 virus that uses an RNA intermediate during replication. Most people who come into contact with the virus are able to clear the infection alone although some cannot and usually progress to fulminant hepatitis. It can cause sever liver...
